Skip to content

Dexamethasone vs Bicarbonate to Intracuff Lignocaine 2% in General Anaesthesia

Comparision of Addition of Dexamethasone vs Bicarbonate to Intracuff Lignocaine 2% in Terms of Extubation Characteristics and Patient Satisfaction Undergoing General Anaesthesia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03833947
Enrollment
100
Registered
2019-02-07
Start date
2019-03-15
Completion date
2019-12-30
Last updated
2020-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Anesthesia; Adverse Effect, Anesthesia Intubation Complication

Keywords

Intracuff Dexamethasone, Intracuff Alkalinized lignocaine, General anesthesia

Brief summary

This study is designed to evaluate and compare the effect on hemodynamics, extubation response and patients satisfaction score in patients with ETT cuff filled with either mixture of lignocaine with sodium bicarbonate or with a mixture of lignocaine with dexamethasone.

Detailed description

Objective Recently multiple studies have shown better outcomes with usage of dexamethasone or alkalinized lignocaine instead of air for filling endotracheal tube (ETT) cuff. So this study is designed to evaluate and compare the effect on hemodynamics, extubation response and patients satisfaction score in patients with ETT cuff filled with either mixture of lignocaine with sodium bicarbonate or with a mixture of lignocaine with dexamethasone. Design and setting: This is a prospective single blind, randomized controlled study at the department of anesthesiology, JNMCH, AMU, Aligarh. Materials and methods: Investigators plan to include 100 patients of age group within 18-60 years with American Society of Anesthesiologists (ASA) class I & II, posted for elective surgery of duration \>120 minutes, performed under general anesthesia; administered as per institutional protocols. Patients with ASA III & IV, cardiovascular morbidities, known drug allergy, pregnancy will be excluded from the study. Patients will be divided into two groups randomly according to chit-in-box method, viz Group A & Group D with fifty patients in each group. Patient group allocation, preparation of drug mixture for endotracheal cuff filling as per group assigned and analysis of observed data will be done by a separate anesthetist not involved in the perioperative management of the patient. In patients belonging to Group (A), ETT cuff will be filled with mixture of 7.5% sodium bicarbonate with 2% lignocaine in the proportions of 0.5: 9.5 ml while in Group D the ETT cuff will be filled with mixture of dexamethasone with 2% lignocaine in the proportions of 0.5: 9.5 ml . The cuff of the ETT will be slowly inflated until no leak is heard at all during the peak airway pressure of the ventilator cycle while auscultating the trachea . Volume of drug mixture in the cuff will be noted at start and end of surgery. Total duration of anesthesia will be noted. Hemodynamic stability at the time of extubation will be meausred in terms of changes in rate pressure product (RPP) which will denote the product of heart rate and systolic blood pressure. RPP values recorded immediately after stoppage of the anesthetic agents at the end of surgery will be compared to the values measured just after the extubation of trachea. Patient's satisfaction from anesthesia given will be recorded, based on VAS. The presence of coughing and bucking will also be noted. Incidence of postoperative sore throat and cough will be recorded at 1 hour and 24 hours post extubation. The results will be presented in number, percentage, mean, and standard deviation as appropriate. Appropriate statistical tests will be applied and P value less than 0.05 will be considered as statistically significant.

Interventions

DRUGlignocaine+bicarbonate

ETT cuff was filled with mixture of 2% lignocaine with bicarbonate

DRUGlignocaine+dexamethasone

ETT cuff was filled with mixture of 2% lignocaine with dexamethasone

Sponsors

Aligarh Muslim University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* American Society of Anesthesiologists (ASA) class I & II. * Elective surgery * General anesthesia of duration \>120 minutes.

Exclusion criteria

* Patients with ASA III & IV. * Known Cardiovascular morbidities. * Pregnancy. * Allergic to used drugs.

Design outcomes

Primary

MeasureTime frameDescription
smoothness of extubationtime from adequate reversal of anaesthesia & muscle paralysis (head holding >5sec, eye opening on command, train of four ratio >0.9) till removal of endotracheal tube.Grade 1= coughing, bucking, tube biting, agitatation present. Grade 2= mild bucking/coughing. Grade 3= completely comfortable, tolerating tube in situ, no coughing/bucking/agitation.
patient satisfaction scorepost operative 1 hourrated on visual analog scale varying 0 to 10; where 0 is worst experience and 10 is best. completely

Secondary

MeasureTime frameDescription
Haemodynamic stability at the time of extubation.values of product of systolic blood pressure and heart rate will be compared after stopping the anesthetic agents and immediately after the extubationRate pressure product (RPP); \[RPP=Product of systolic blood pressure(mmHg) and heart rate (beats per min)\] measured after stopping the anaesthetic agents at the end of surgery will be taken as baseline and then compared to values measured immediately after the removal of endotracheal tube.
amount of drug diffused through endotracheal tube cufffrom start till end of surgery.Volume of drug mixture in the cuff was noted at start and end of surgery.
incidence of post operative cough and sore throatafter 1 and 24 hour post extubationincidence of post operative cough and sore throat

Other

MeasureTime frameDescription
duration of surgeryduration of surgeryduration of surgery

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026